Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.4 GBX | +0.80% | -1.81% | -12.38% |
Apr. 24 | Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results | CI |
Apr. 22 | Capital & Regional picks Gerry Murphy as non-exec director | AN |
Sales 2023 * | 23.99M 30.02M | Sales 2024 * | 27.18M 34M | Capitalization | 110M 137M |
---|---|---|---|---|---|
Net income 2023 * | 15M 18.77M | Net income 2024 * | 19M 23.77M | EV / Sales 2023 * | 10.8 x |
Net Debt 2023 * | 150M 188M | Net Debt 2024 * | 153M 191M | EV / Sales 2024 * | 9.64 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 350 |
Yield 2023 * |
11.4% | Yield 2024 * |
12% | Free-Float | 18.71% |
Latest transcript on Capital & Regional plc
1 day | +0.40% | ||
1 week | -1.83% | ||
Current month | -2.78% | ||
1 month | -1.83% | ||
3 months | -9.25% | ||
6 months | -5.86% | ||
Current year | -12.40% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 17-06-12 | |
Stuart Wetherly
DFI | Director of Finance/CFO | - | 12-09-30 |
Sara Jennings
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leon Sasse
BRD | Director/Board Member | 59 | 19-12-08 |
Ian Krieger
BRD | Director/Board Member | - | 14-11-30 |
Laura Whyte
BRD | Director/Board Member | - | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 50.47 | +0.94% | 73 747 |
24-04-24 | 50 | +0.10% | 24,665 |
24-04-23 | 49.95 | -0.10% | 205,587 |
24-04-22 | 50 | 0.00% | 248,802 |
24-04-19 | 50 | -2.72% | 167,458 |
Delayed Quote London S.E., April 25, 2024 at 04:25 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.40% | 136M | |
+0.12% | 46.52B | |
-13.05% | 12.49B | |
-11.03% | 10.99B | |
-22.69% | 11.04B | |
-4.55% | 7.52B | |
-6.49% | 6.56B | |
-5.15% | 5.72B | |
-7.28% | 5.86B | |
-4.99% | 4.77B |
- Stock Market
- Equities
- CAL Stock